Untransduced T Cells (PRAME TCR-T Negative Control)

BPS Bioscience

Untransduced T Cells (PRAME TCR-T Negative Control)

23

Other Application

Research Use Only

PRAME

PRAME nuclear receptor transcriptional regulator

CT130, MAPE, OIP-4, OIP4, melanoma antigen preferentially expressed in tumors, Opa-interacting protein OIP4, cancer/testis antigen 130, opa-interacting protein 4, preferentially expressed antigen in melanoma, preferentially expressed antigen of melanoma

Melanoma antigen preferentially expressed in tumors

The Untransduced T Cells (PRAME TCR-T Negative Control) were produced by mock lentiviral transduction of human primary CD4+ and CD8+ T cells. These cells are subjected to comparable manipulations as TCR (T cell receptor)-T cells: activation, spinoculation (without lentivirus), and antigen specific stimulation. These T cells are designed as a negative control in experiments using lentivirus-transduced TCR-T cells, such as PRAME TCR-T Cells (#82391).

Liquid Nitrogen

41116106

Human